Chemocentryx, Inc.

Peter Staehr

Rajinder Paul Singh

Thomas J Schall

Shijie Li

Provided herein are methods for treating a subject suffering from a cutaneous neutrophilic inflammatory disease comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein each variable position is as defined herein. In some embodiments, the cutaneous neutrophilic inflammatory disease is Hidradenitis suppurativa (HS).

Growing community of inventors

San Carlos, CA, United States of America

Peter Staehr